Impact of JAK2(V617F) mutation status on treatment response to anagrelide in essential thrombocythemia: An observational, hypothesis-generating study
- Nicola Cascavilla
- , Valerio De Stefano
- , Fabrizio Pane
- , Alessandro Pancrazzi
- , Alessandra Iurlo
- , Marco Gobbi
- , Francesca Palandri
- , Giorgina Specchia
- , A. Marina Liberati
- , Mariella D’Adda
- , Gianluca Gaidano
- , Rajmonda Fjerza
- , Heinrich Achenbach
- , Jonathan Smith
- , Paul Wilde
- , Alessandro M. Vannucchi
Research output: Contribution to journal › Article › peer-review